IL1B and Insulin resistance: In line with these recent findings, therapies aimed at blocking systemic TNF-α and IL-1β do not ameliorate insulin resistance in patients.73,74 Thus, the relationship between inflammation in white adipose tissue and insulin resistance appears to be more intricate than the conventional paradigm of adipose tissue inflammation causing insulin resistance.